These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18827796)

  • 1. Vitamin D in chronic kidney disease: is the jury in?
    de Boer IH; Kestenbaum B
    Kidney Int; 2008 Oct; 74(8):985-7. PubMed ID: 18827796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and glucose metabolism in chronic kidney disease.
    de Boer IH
    Curr Opin Nephrol Hypertens; 2008 Nov; 17(6):566-72. PubMed ID: 18941348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes with active versus nutritional vitamin D compounds in chronic kidney disease.
    Kalantar-Zadeh K; Kovesdy CP
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1529-39. PubMed ID: 19661219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D in patients with kidney disease: cautiously optimistic.
    Thadhani R; Wolf M
    Adv Chronic Kidney Dis; 2007 Jan; 14(1):22-6. PubMed ID: 17200040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D in kidney disease: pathophysiology and the utility of treatment.
    Qazi RA; Martin KJ
    Endocrinol Metab Clin North Am; 2010 Jun; 39(2):355-63, table of contents. PubMed ID: 20511057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Making sense of the latest advice on vitamin D therapy.
    Monk RD; Bushinsky DA
    J Am Soc Nephrol; 2011 Jun; 22(6):994-8. PubMed ID: 21617120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD.
    Agarwal R
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1523-8. PubMed ID: 19478099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renoprotective effects of vitamin D analogs.
    Li YC
    Kidney Int; 2010 Jul; 78(2):134-9. PubMed ID: 19471320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of vitamin D in chronic kidney disease patients.
    Gal-Moscovici A; Sprague SM
    Kidney Int; 2010 Jul; 78(2):146-51. PubMed ID: 20505658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D and its analogues: do they protect against cardiovascular disease in patients with kidney disease?
    Levin A; Li YC
    Kidney Int; 2005 Nov; 68(5):1973-81. PubMed ID: 16221197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
    Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK
    Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation.
    Andress DL
    Kidney Int; 2006 Jan; 69(1):33-43. PubMed ID: 16374421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and parathyroid hormone in general populations: understandings in 2009 and applications to chronic kidney disease.
    Johal M; Levin A
    Clin J Am Soc Nephrol; 2009 Sep; 4(9):1508-14. PubMed ID: 19556377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of secondary hyperparathyroidism by vitamin D receptor agonists in chronic kidney disease.
    Sprague SM; Coyne D
    Clin J Am Soc Nephrol; 2010 Mar; 5(3):512-8. PubMed ID: 20133492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kidney and bone update : the 5-year history and future of CKD-MBD. Progress in therapy of CKD-MBD with vitamin D receptor activators].
    Shoji T
    Clin Calcium; 2012 Jul; 22(7):1073-81. PubMed ID: 22750940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the "trade-off" hypothesis.
    Gutiérrez OM
    Clin J Am Soc Nephrol; 2010 Sep; 5(9):1710-6. PubMed ID: 20507957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of 'K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease' after the introduction of cinacalcet in a population of patients on chronic haemodialysis.
    Arenas MD; Alvarez-Ude F; Gil MT; Moledous A; Malek T; Nuñez C; Devesa R; Carretón MA; Soriano A
    Nephrol Dial Transplant; 2007 Jun; 22(6):1639-44. PubMed ID: 17277339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D analogs: therapeutic applications and mechanisms for selectivity.
    Brown AJ; Slatopolsky E
    Mol Aspects Med; 2008 Dec; 29(6):433-52. PubMed ID: 18554710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new role for vitamin D receptor activation in chronic kidney disease.
    Valdivielso JM; Cannata-Andía J; Coll B; Fernández E
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1502-9. PubMed ID: 19625376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor activation and survival in chronic kidney disease.
    Kovesdy CP; Kalantar-Zadeh K
    Kidney Int; 2008 Jun; 73(12):1355-63. PubMed ID: 18288097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.